Improved Stock Price Performance of HealthCare Related Companies - Research Report on Omega, BioScrip, Accuray, Stereotaxis and Sagent Pharmaceuticals Editor Note: For more information about this release, please scroll to bottom.

NEW YORK, December 20, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Omega Healthcare Investors Inc. (NYSE: OHI), BioScrip Inc. (NASDAQ: BIOS), Accuray Incorporated (NASDAQ: ARAY), Stereotaxis Inc. (NASDAQ: STXS), and Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Omega Healthcare Investors Inc. Research Report

On December 17, 2013, Omega Healthcare Investors Inc.'s (Omega) stock reflected an increase of 1.48% as it closed the day at $30.23 per share. For the past three trading day period, the Company' stock gained 0.37%, slightly lower as compared to the Dow Jones Industrial Average which increased by 0.86% over the same three day trading period. The Full Research Report on Omega Healthcare Investors Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/063c_OHI

--

BioScrip Inc. Research Report

On December 17, 2013, BioScrip Inc.'s (BioScrip) stock increased significantly by 8.87%, closing the day at $7.12 per share. Over the previous three day trading period, the Company's stock went up by 8.36%, beating the Nasdaq composite which gained 0.63%, during the same three day trading period. The Full Research Report on BioScrip Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/4879_BIOS

--

Accuray Incorporated Research Report

On December 17, 2013, Accuray Incorporated's (Accuray) stock closed the day at $8.41 per share, reflecting a 2.94% increase over the previous day's closing price. The Company's stock went up by 7.0% over the past three day trading period, compared to the Dow Jones Industrial Average which went up by 0.86% during the same three day trading session. The Full Research Report on Accuray Incorporated - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/36bf_ARAY

--

Stereotaxis Inc. Research Report

On December 17, 2013, Stereotaxis Inc.'s (Stereotaxis) stock reflected a massive increase of 10.98%, to close the day at $3.64 per share. For the past three trading day period, the Company's shares increased 14.83%, compared to the S&P 500 which went up by 0.31% during the same three day trading session. The Full Research Report on Stereotaxis Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/b071_STXS

--

Sagent Pharmaceuticals, Inc. Research Report

On December 17, 2013, Sagent Pharmaceuticals, Inc.'s (Sagent Pharmaceuticals) stock went up by 1.92%, closing the day at $23.93 per share. Over the previous three day trading session, Sagent Pharmaceuticals' stock reflected an increase of 6.07%, compared to the Dow Jones Industrial Average which went up by 0.86%, and the Nasdaq composite which went up by 0.63%, during the same three day trading period. The Full Research Report on Sagent Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/a901_SGNT

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://AnalystsCorner.com

 

SOURCE Analysts' Corner




Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.